Request Demo
Last update 28 Jan 2026
Wharton's Jelly Mesenchymal Stem Cell(PT. Prodia Stem Cell Indonesia)
Last update 28 Jan 2026
Overview
Basic Info
Drug Type Mesenchymal stem cell therapy |
Synonyms WJ-MSCs(PT. Prodia Stem Cell Indonesia) |
Target- |
Action- |
Mechanism Stem cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Wharton's Jelly Mesenchymal Stem Cell(PT. Prodia Stem Cell Indonesia)NCT05279768
Potential Use of Umbilical Cord Mesenchymal Stem Cells and Secretoms for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.
IRCT20210103049925N1
Therapeutic and immunogenic effects of implanting Wharton’s jelly-derived mesenchymal stem cells into the knee joint of osteoarthritis patients in grade 2 & 3 Kellgren Lawrence scale: an interventional randomized double-blind placebo controlled clinical trial, phase I
100 Clinical Results associated with Wharton's Jelly Mesenchymal Stem Cell(PT. Prodia Stem Cell Indonesia)
Login to view more data
100 Translational Medicine associated with Wharton's Jelly Mesenchymal Stem Cell(PT. Prodia Stem Cell Indonesia)
Login to view more data
100 Patents (Medical) associated with Wharton's Jelly Mesenchymal Stem Cell(PT. Prodia Stem Cell Indonesia)
Login to view more data
100 Deals associated with Wharton's Jelly Mesenchymal Stem Cell(PT. Prodia Stem Cell Indonesia)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Infertility | Phase 2 | Indonesia | 01 Sep 2022 | |
| Insulin Resistance | Phase 2 | Indonesia | 01 Sep 2022 | |
| Polycystic Ovary Syndrome | Phase 2 | Indonesia | 01 Sep 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | 18 | cjpaxshwix(uzlevmsufz) = fwphwxzxzm rccaczqzha (qikporqoqc ) | Positive | 29 Aug 2020 | |||
BM-MSC | cjpaxshwix(uzlevmsufz) = neyxxxacze rccaczqzha (qikporqoqc ) |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free